Long-term Safety Follow-up in Recipients Who Previously Received Medeor's Cellular Immunotherapy Products

Overview

About this study

The purpose of this study is to evaluate the long-term safety in patients previously treated with Medeor cellular immunotherapy products in a Medeor parent study.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

1. Able and willing to fully comply with all study procedures and restrictions.

2. Able to understand and provide written, signed, and dated informed consent to
participate in the study in accordance with ICH GCP Guideline and all applicable local
regulations.

3. Have previously completed a Medeor study and received a Medeor cellular immunotherapy
product

Exclusion Criteria:

1. Has any condition or circumstance, which in the opinion of the Investigator would
significantly interfere with the subject's protocol compliance or put the subject at
increased risk.

2. Unable or unwilling to provide written, signed, and dated informed consent to
participate in the study.

3. Has undergone a second organ transplant with an organ derived from an individual other
than the donor of the transplant kidney received during a Medeor study.

Eligibility last updated 8/8/22. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Mark Stegall, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Mark Stegall, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials